T. Rowe Price Associates’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
147,092
+82,200
| +127% | +$6.03M | ﹤0.01% | 1096 |
|
|
2025
Q1 | $7.41M | Buy |
64,892
+10,139
| +19% | +$1.16M | ﹤0.01% | 1167 |
|
|
2024
Q4 | $2.76M | Buy |
54,753
+1,825
| +3% | +$92K | ﹤0.01% | 1485 |
|
|
2024
Q3 | $2.45M | Buy |
52,928
+1,793
| +4% | +$83K | ﹤0.01% | 1545 |
|
|
2024
Q2 | $1.66M | Buy |
51,135
+2,709
| +6% | +$88K | ﹤0.01% | 1649 |
|
|
2024
Q1 | $1.22M | Sell |
48,426
-3,109
| -6% | -$78.3K | ﹤0.01% | 1817 |
|
|
2023
Q4 | $1.67M | Buy |
51,535
+2,850
| +6% | +$92.6K | ﹤0.01% | 1624 |
|
|
2023
Q3 | $1.33M | Buy |
48,685
+2,042
| +4% | +$55.7K | ﹤0.01% | 1658 |
|
|
2023
Q2 | $1.04M | Buy |
46,643
+832
| +2% | +$18.5K | ﹤0.01% | 1785 |
|
|
2023
Q1 | $993K | Buy |
45,811
+2,201
| +5% | +$47.7K | ﹤0.01% | 1791 |
|
|
2022
Q4 | $886K | Buy |
43,610
+2,082
| +5% | +$42.3K | ﹤0.01% | 1839 |
|
|
2022
Q3 | $1.07M | Buy |
41,528
+5,731
| +16% | +$147K | ﹤0.01% | 1716 |
|
|
2022
Q2 | $851K | Buy |
35,797
+7,230
| +25% | +$172K | ﹤0.01% | 1971 |
|
|
2022
Q1 | $643K | Buy |
28,567
+4,030
| +16% | +$90.7K | ﹤0.01% | 2222 |
|
|
2021
Q4 | $486K | Sell |
24,537
-18,226
| -43% | -$361K | ﹤0.01% | 2392 |
|
|
2021
Q3 | $842K | Buy |
42,763
+200
| +0.5% | +$3.94K | ﹤0.01% | 2126 |
|
|
2021
Q2 | $936K | Buy |
42,563
+1,561
| +4% | +$34.3K | ﹤0.01% | 2092 |
|
|
2021
Q1 | $975K | Sell |
41,002
-135
| -0.3% | -$3.21K | ﹤0.01% | 2059 |
|
|
2020
Q4 | $1.08M | Buy |
+41,137
| New | +$1.08M | ﹤0.01% | 1903 |
|
|
2017
Q1 | – | Sell |
-88,815
| Closed | -$645K | – | 2573 |
|
|
2016
Q4 | $645K | Buy |
+88,815
| New | +$645K | ﹤0.01% | 1947 |
|
|
2016
Q2 | – | Sell |
-100,454
| Closed | -$470K | – | 2517 |
|
|
2016
Q1 | $470K | Hold |
100,454
| – | – | ﹤0.01% | 1997 |
|
|
2015
Q4 | $500K | Sell |
100,454
-286,181
| -74% | -$1.42M | ﹤0.01% | 1959 |
|
|
2015
Q3 | $1.45M | Buy |
+386,635
| New | +$1.45M | ﹤0.01% | 1606 |
|